Moderna shares surge after it says its experimental mRNA cancer treatment passed a key test
First publishedAug 19, 12:12 UTC
Last updatedAug 20, 04:26 UTC · 5m ago
1 outlet
Investing.com · Stock Market1 outlet
Seattle Times
2 outlets over time — hover a bar for its window & outletslast updated
Answer
Moderna shares more than doubled after announcing initial results from a study of an experimental cancer treatment.
Reported by 2 outlets — Seattle Times, Investing.com · Stock Market. See all sources ↓
Read the full report at Seattle Times ↗
Why it matters
2 outlets are covering this world story — one to watch as reporting develops.
In brief
- What's the story?
- Moderna shares more than doubled after announcing initial results from a study of an experimental cancer treatment.
- How widely is it covered?
- 2 outlets, average source rating 6.0/10.
- When was it last updated?
- 5m ago.
Different angles across outlets
Coverage map
How outlets are framing the same story
Here's how each outlet is covering the story — compare their headlines and timing at a glance.
- Coverage card2 outlets1CoverageScouting report
Moderna shares surge after it says its experimental mRNA cancer treatment passed a key test
Sources2TypeCoverage
Sources (2)
Avg source rating 6.0/10Processing cluster
A1A2A3B1B2B3